O112 : HBsAg clearance after addition of 48 weeks of pegifn...

Journal of Hepatology 2015 / 04 Vol. 62

O112 : HBsAg clearance after addition of 48 weeks of pegifn in HBeAg negative CHB patients on nucleos(T)ide therapy with undetectable hbvdna for at least one year: final results from ANRS-HB06 pegan study: multicenter randomized controlled phase III trial

Bourliere, M., Rabiega, P., Ganne-Carrie, N., Serfaty, L., Marcellin, P., Pouget, N., Guyader, D., Hezode, C., Picon, M., Causse, X., Leroy, V., Bronowicki, J.P., Riachi, G., Rosa, I., Attali, P., Mol
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30131-8
Date:
April, 2015
File:
PDF, 42 KB
english, 2015
Conversion to is in progress
Conversion to is failed